The U.S. government has been in negotiations with Pfizer for 1.7 million courses of treatment, with an additional option for 3.3 million at a price of $700 per treatment, implying a potential revenue of as high as $3.5 billion from the U.S. government alone. I own shares and would like to sell covered calls but if big news comes out on the Covid pill approval this stock could fly. Any opinions would be appreciated.$Pfizer(PFE)$